Protein A Resin Market Size, Prominent Players and Key Figures Reviewed in Latest Research Report 2022-2028

The global protein A resin market is projected to reach USD 2.1 billion by 2028 from USD 1.2 billion in 2022, growing at a CAGR of 9.8% during the forecast period. Rising technological advancements primarily drive the growth of this market in protein A resin, rise in demand for miniaturize protein engineered product used in disease diagnoses and therapeutics. equipment further supports the market growth. However, higher initial investment impedes the market growth.

Protein A Resin Market: Competitive Landscape and Key Developments

The protein A resin business is very competitive, with both established companies and newcomers competing for the same market share. As of 2022, the key players operating in the global protein A resin market are Danaher Corporation (US), Merck KGAa (Germany), Repligen Corporation (US), Tosoh Bioscience LLC (Japan), Thermo Fisher Scientific (US), Agilent Technologies Inc. (US), and PerkinElmer (US) among others.

Get PDF Brochure With Latest Insights @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=19196962

Danaher Corporation (US)

Danaher Corporation is a US-based company that designs, manufactures, and markets medical, industrial, and commercial products and services. The company operates through three business segments, namely, Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences business segment offers protein A resin products. This segment is further classified into Filtration, Mass Spectrometry, Cellular Analysis, Lab Automation & Centrifugation, Microscopy, and Genomics Consumables. In FY 2021, the US accounted for 38.3% of the company’s revenue, followed by China (13.5%), Germany (5%), and all other countries (43.2%). The company's presence across diverse geographies shields it from risks associated with adverse economic trends in a single region. It also provides it with exposure to a large addressable market, thus enhancing its topline.

Merck KGAA (Germany)

Merck KGaA is another major player in the protein A resin market. The company is a leading provider of chromatography consumables across the globe. It primarily focuses on expansions and new product launches as its key growth strategies to expand its presence in the global market. Merck has a significant focus on innovation. Over the last few years, the company has increased its R&D activities with a focus on providing its customers with advanced products. Through strong R&D, the company is extending its patent portfolio, which can help Merck gain an advantage over its competitors. Merck is consistently introducing new chromatography products in the market. The company is also focused on enhancing its geographic presence through expansions.

Objectives of the Study

To define, describe, and forecast the protein A resin market on the basis of product, type, application, end user, and region
To provide detailed information regarding the major factors influencing the growth potential of the global market (drivers, restraints, opportunities, challenges, and trends)
To analyze the micro markets with respect to individual growth trends, future prospects, and contributions to the global market
To analyze key growth opportunities in the global market for key stakeholders and provide details of the competitive landscape for market leaders
To forecast the size of market segments and/or subsegments with respect to five major regions, namely, North America (US and Canada), Europe (Germany, France, the UK, Italy, Spain, and the RoE), Asia Pacific (Japan, China, India, Australia, South Korea, and the RoAPAC), and rest of the world.
To profile the key players in the global market and comprehensively analyze their market shares and core competencies
To track and analyze the competitive developments undertaken in the global protein A resin market, such as product launches, agreements, expansions, and & acquisitions

Buy This Complete Business Report @ https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=19196962

Global Protein A Resin Market – Regional Scope

The global Protein A resin market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Among these, the North America region is expected to hold the largest share in the global Protein A resin market. This can be attributed to the presence of well-established biopharmaceutical companies in the region and the availability of advanced infrastructure for biopharmaceutical manufacturing. Moreover, the rapid growth of the biopharmaceutical industry in the region is also expected to propel the growth of the Protein A resin market in North America.

Europe is the second-largest region in the global Protein A resin market, due to the presence of a large number of biopharmaceutical companies and contract research organizations in the region. The Asia Pacific is expected to be the fastest-growing region in the global Protein A resin market, owing to the increasing demand for biopharmaceuticals in the region. The growing research and development activities in the region are also expected to contribute to the growth of the Protein A resin market in the region.

Recent Developments

In September 2022, As part of its charitable efforts through the Agilent Foundation, Agilent Technologies partnered with Delaware State University (DSU) to boost the number of minority students who choose STEM careers.
In October 2021, Tosoh Biosciences LLC completed the acquisition of Semba Biosciences, a privately held leading innovator in the field of multi-column chromatography (MCC) instrumentation and technology for the downstream purification of biologics.
In September 2021, Repligen and Navigo completed their co-development of a novel affinity ligand that addresses aggregation issues associated with pH-sensitive antibodies and Fc-fusion proteins. This ligand, NGL-Impact HipH, is produced and supplied to Purolite for use in a platform usage resin product.
In May 2021, The Life Sciences business of GE Healthcare was acquired by Danaher Corporation and rebranded as Cytiva.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=19196962

About MarketsandMarkets™

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.